Package 60505-3250-6

{"route": ["ORAL"], "spl_id": "57b50cc9-4140-66b7-ec3c-e10a213dae03", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["205328"], "spl_set_id": ["87095352-c088-74b1-7be0-d3e293a90611"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (60505-3250-6)", "package_ndc": "60505-3250-6", "marketing_start_date": "20140103"}], "brand_name": "Lamivudine", "product_id": "60505-3250_57b50cc9-4140-66b7-ec3c-e10a213dae03", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60505-3250", "generic_name": "Lamivudine", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "100 mg/1"}], "application_number": "ANDA202941", "marketing_category": "ANDA", "marketing_start_date": "20140103", "listing_expiration_date": "20261231"}